Godsey & Gibb Inc’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-342
Closed -$25.7K 454
2025
Q3
$25.7K Buy
+342
New +$25.5K ﹤0.01% 210
2025
Q1
Sell
-50
Closed -$3.91K 393
2024
Q4
$3.91K Hold
50
﹤0.01% 316
2024
Q3
$4.69K Hold
50
﹤0.01% 370
2024
Q2
$3.9K Sell
50
-30
-38% -$2.45K ﹤0.01% 353
2024
Q1
$7.27K Sell
80
-37
-32% -$3.08K ﹤0.01% 295
2023
Q4
$9.05K Buy
117
+36
+44% +$2.52K ﹤0.01% 274
2023
Q3
$5.51K Hold
81
﹤0.01% 277
2023
Q2
$6.58K Buy
81
+50
+161% +$3.99K ﹤0.01% 289
2023
Q1
$2.54K Buy
+31
New +$2.21K ﹤0.01% 298

Other funds holding GEHC

Godsey & Gibb Inc's GEHC Position: Q4 2025 in Review

Godsey & Gibb Inc sold out of GE HealthCare (GEHC) in Q4 2025, closing a stake of 342 shares — an estimated $25.7K sold.

Godsey & Gibb Inc first reported a position in GEHC in Q1 2023 and held it in 9 quarters. The position peaked at $25.7K in Q3 2025. 1,335 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

  • Godsey & Gibb Inc reported no remaining GE HealthCare position as of Q4 2025 after selling out during the quarter.
  • Godsey & Gibb Inc sold 342 GE HealthCare shares in Q4 2025, an estimated $25.7K.
  • Godsey & Gibb Inc first reported a position in GE HealthCare in Q1 2023 and held it in 9 quarters.
  • Godsey & Gibb Inc's GE HealthCare position peaked at $25.7K in Q3 2025.
  • 1,335 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on Godsey & Gibb Inc's 13F filing for Q4 2025, filed 27 Jan 2026.